BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12747621)

  • 1. Bisphosphonate mucosal injury--the end of the story?
    Lanza F
    Dig Liver Dis; 2003 Feb; 35(2):67-70. PubMed ID: 12747621
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug-induced esophagitis, esophageal ulcer, gastro-duodenal ulcer, and small intestinal ulcer].
    Matsuhashi N; Sakurai Y
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():504-8. PubMed ID: 18074591
    [No Abstract]   [Full Text] [Related]  

  • 3. Endoscopic comparison of esophageal and gastroduodenal effects of risedronate and alendronate in postmenopausal women.
    Lanza FL; Hunt RH; Thomson AB; Provenza JM; Blank MA
    Gastroenterology; 2000 Sep; 119(3):631-8. PubMed ID: 10982755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esophageal irritation due to alendronate sodium tablets: possible mechanisms.
    Peter CP; Handt LK; Smith SM
    Dig Dis Sci; 1998 Sep; 43(9):1998-2002. PubMed ID: 9753265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal irritant potential of a potassium-sparing diuretic and of wax-matrix potassium chloride.
    Ryan JR; McMahon FG; Akdamar K; Ertan A; Agrawal N
    Clin Pharmacol Ther; 1984 Jan; 35(1):90-3. PubMed ID: 6690174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non-steroidal anti-inflammatory agents and digestive lesions].
    Bellanger J; Pointereau-Bellanger A
    Ann Gastroenterol Hepatol (Paris); 1989 Nov; 25(6):237-48. PubMed ID: 2694919
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical impact of upper gastrointestinal tract injuries in glyphosate-surfactant oral intoxication.
    Chang CY; Peng YC; Hung DZ; Hu WH; Yang DY; Lin TJ
    Hum Exp Toxicol; 1999 Aug; 18(8):475-8. PubMed ID: 10462358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upper gastrointestinal tract safety profile of alendronate: the fracture intervention trial.
    Bauer DC; Black D; Ensrud K; Thompson D; Hochberg M; Nevitt M; Musliner T; Freedholm D
    Arch Intern Med; 2000 Feb; 160(4):517-25. PubMed ID: 10695692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of ulcer soars with combination of arthritis drugs.
    Gottlieb S
    West J Med; 2001 Apr; 174(4):236. PubMed ID: 11290669
    [No Abstract]   [Full Text] [Related]  

  • 10. [Surgical complications of corticoid therapy].
    Patel JC
    Presse Med (1893); 1968 Feb; 76(10):461-2. PubMed ID: 5639857
    [No Abstract]   [Full Text] [Related]  

  • 11. Major gastrointestinal ulceration in association with Piroxicam therapy.
    Irving AD; Sadek SA
    J R Coll Surg Edinb; 1983 Mar; 28(2):121-2. PubMed ID: 6602880
    [No Abstract]   [Full Text] [Related]  

  • 12. [Structure and function of the mucous membrane of the stomach and duodenum in workers in the aluminum industry].
    Medvedeva VN
    Gig Tr Prof Zabol; 1983 Nov; (11):25-8. PubMed ID: 6654123
    [No Abstract]   [Full Text] [Related]  

  • 13. Esophagitis and alendronate.
    Liberman UI; Hirsch LJ
    N Engl J Med; 1996 Oct; 335(14):1069-70. PubMed ID: 8801453
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary amino-bisphosphonates: a new class of gastrotoxic drugs--comparison of alendronate and aspirin.
    Graham DY; Malaty HM; Goodgame R
    Am J Gastroenterol; 1997 Aug; 92(8):1322-5. PubMed ID: 9260798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of aminobisphosphonates on the superior digestive tract mucosa].
    Man F
    Acta Gastroenterol Latinoam; 2001 May; 31(2):103-5. PubMed ID: 11471318
    [No Abstract]   [Full Text] [Related]  

  • 16. [Digestive complications of corticoid treatment].
    Sicot C
    Rev Prat; 1975 Mar; 25(15):1123-9. PubMed ID: 169563
    [No Abstract]   [Full Text] [Related]  

  • 17. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1996 May 22-29; 275(20):1534. PubMed ID: 8622234
    [No Abstract]   [Full Text] [Related]  

  • 18. Upper gastrointestinal tract injury in patients receiving kayexalate (sodium polystyrene sulfonate) in sorbitol: clinical, endoscopic, and histopathologic findings.
    Abraham SC; Bhagavan BS; Lee LA; Rashid A; Wu TT
    Am J Surg Pathol; 2001 May; 25(5):637-44. PubMed ID: 11342776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmarketing surveillance indicates need for better education of patients taking alendronate.
    Am J Health Syst Pharm; 1996 May; 53(9):986. PubMed ID: 8744454
    [No Abstract]   [Full Text] [Related]  

  • 20. Alendronate and naproxen are synergistic for development of gastric ulcers.
    Graham DY; Malaty HM
    Arch Intern Med; 2001 Jan; 161(1):107-10. PubMed ID: 11146706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.